Parse Biosciences

company

About

Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
Bioinformatics,Biotechnology,Genetics,Life Science
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Parse Bio is a biotechnology startup company developing single-cell sequencing kit solutions for researchers.

By using combinatorial cDNA barcoding within cells themselves, Parse Biosciences’s technology allows researchers to eliminate the need for complex and expensive microfluidic instruments. Additionally, the company’s technology enables samples to be fixed, frozen, and stored, allowing researchers to separate out the sample extraction from downstream library preparation steps. This capability empowers researchers to run fixed samples collected on different dates together in a single experiment, providing greater control over sample handling and reducing handling errors. Split Biosciences rebranded as Parse Biosciences in 2020.

The Seattle, Washington-based biotech company was established in 2018 by Alex Rosenberg, Charlie Roco, and Georg Friedrich Seelig.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$225K
Parse Biosciences has raised a total of $225K in funding over 2 rounds. Their latest funding was raised on Jan 29, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 29, 2019 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Parse Biosciences is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant